{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,27]],"date-time":"2026-08-27T19:31:14Z","timestamp":1787859074810,"version":"build-2784847793"},"reference-count":19,"publisher":"Oxford University Press (OUP)","issue":"1","license":[{"start":{"date-parts":[[2018,3,7]],"date-time":"2018-03-07T00:00:00Z","timestamp":1520380800000},"content-version":"vor","delay-in-days":65,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2018,1,1]]},"DOI":"10.1093\/rap\/rky002","type":"journal-article","created":{"date-parts":[[2018,3,7]],"date-time":"2018-03-07T07:05:04Z","timestamp":1520406304000},"source":"Crossref","is-referenced-by-count":26,"title":["Distinctive clinical phenotype of anti-centromere antibody-positive diffuse systemic sclerosis"],"prefix":"10.1093","volume":"2","author":[{"given":"Joana","family":"Caetano","sequence":"first","affiliation":[{"name":"Systemic Immunomediated Diseases Unit, Department of Medicine IV, Fernando Fonseca Hospital, Amadora, Portugal"},{"name":"Centre for Rheumatology and Connective Tissue Diseases, University College London Medical School, Royal Free Hospital, London, UK"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Svetlana I","family":"Nihtyanova","sequence":"additional","affiliation":[{"name":"Centre for Rheumatology and Connective Tissue Diseases, University College London Medical School, Royal Free Hospital, London, UK"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jennifer","family":"Harvey","sequence":"additional","affiliation":[{"name":"Department of Clinical Immunology, Royal Free Hospital, London, UK"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Christopher P","family":"Denton","sequence":"additional","affiliation":[{"name":"Centre for Rheumatology and Connective Tissue Diseases, University College London Medical School, Royal Free Hospital, London, UK"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Voon H","family":"Ong","sequence":"additional","affiliation":[{"name":"Centre for Rheumatology and Connective Tissue Diseases, University College London Medical School, Royal Free Hospital, London, UK"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"286","published-online":{"date-parts":[[2018,3,7]]},"reference":[{"key":"2019062610014234600_rky002-B1","doi-asserted-by":"crossref","first-page":"35","DOI":"10.1016\/j.semarthrit.2005.03.005","article-title":"Autoantibodies in systemic sclerosis","volume":"35","author":"Steen","year":"2005","journal-title":"Semin Arthritis Rheum"},{"key":"2019062610014234600_rky002-B2","doi-asserted-by":"crossref","first-page":"112","DOI":"10.1038\/nrrheum.2009.238","article-title":"Autoantibodies as predictive tools in systemic sclerosis","volume":"6","author":"Nihtyanova","year":"2010","journal-title":"Nat Rev Rheumatol"},{"key":"2019062610014234600_rky002-B3","doi-asserted-by":"crossref","first-page":"754","DOI":"10.1136\/ard.2006.062901","article-title":"Clinical risk assessment of organ manifestations in systemic sclerosis: a report from the EULAR Scleroderma Trials and Research group database","volume":"66","author":"Walker","year":"2007","journal-title":"Ann Rheum Dis"},{"key":"2019062610014234600_rky002-B4","doi-asserted-by":"crossref","first-page":"534","DOI":"10.1093\/rheumatology\/keg170","article-title":"The association of antinuclear antibodies with organ involvement and survival in systemic sclerosis","volume":"42","author":"Hesselstrand","year":"2003","journal-title":"Rheumatology"},{"key":"2019062610014234600_rky002-B5","doi-asserted-by":"crossref","first-page":"2828","DOI":"10.1002\/1529-0131(200112)44:12<2828::AID-ART470>3.0.CO;2-U","article-title":"Improvement in skin thickening in systemic sclerosis associated with improved survival","volume":"44","author":"Steen","year":"2001","journal-title":"Arthritis Rheum"},{"key":"2019062610014234600_rky002-B6","doi-asserted-by":"crossref","first-page":"iii14","DOI":"10.1093\/rheumatology\/kep108","article-title":"Skin disease: a cardinal feature of systemic sclerosis","volume":"48","author":"Krieg","year":"2009","journal-title":"Rheumatology"},{"key":"2019062610014234600_rky002-B7","doi-asserted-by":"crossref","first-page":"2737","DOI":"10.1002\/art.38098","article-title":"2013 classification criteria for systemic sclerosis: an American College of Rheumatology\/European League against Rheumatism collaborative initiative","volume":"65","author":"Hoogen","year":"2013","journal-title":"Arthritis Rheum"},{"key":"2019062610014234600_rky002-B8","doi-asserted-by":"crossref","first-page":"940","DOI":"10.1136\/ard.2006.066068","article-title":"Changes in causes of death in systemic sclerosis, 1972\u20132002","volume":"66","author":"Steen","year":"2007","journal-title":"Ann Rheum Dis"},{"key":"2019062610014234600_rky002-B9","doi-asserted-by":"crossref","first-page":"R2","DOI":"10.1186\/ar3495","article-title":"Frequency of disease-associated and other nuclear autoantibodies in patients of the German network for systemic scleroderma: correlation with characteristic clinical features","volume":"13","author":"Mierau","year":"2011","journal-title":"Arthritis Res Ther"},{"key":"2019062610014234600_rky002-B10","first-page":"S96","article-title":"Clinical significance of coexisting antitopoisomerase I and anticentromere antibodies in patients with systemic sclerosis: a EUSTAR group-based study","volume":"31","author":"Heijnen","year":"2013","journal-title":"Clin Exp Rheumatol"},{"key":"2019062610014234600_rky002-B11","doi-asserted-by":"crossref","first-page":"102","DOI":"10.1111\/j.1756-185X.2011.01688.x","article-title":"South Australian Scleroderma Register: autoantibodies as predictive biomarkers of phenotype and outcome","volume":"15","author":"Graf","year":"2012","journal-title":"Int J Rheum Dis"},{"key":"2019062610014234600_rky002-B12","doi-asserted-by":"crossref","first-page":"54","DOI":"10.1007\/s109-1998-8104-5","article-title":"Immunological characterization of heterochromatin protein p25\u03b2 autoantibodies and relationship with centromere autoantibodies and pulmonary fibrosis in systemic scleroderma","volume":"76","author":"Furuta","year":"1998","journal-title":"J Mol Med"},{"key":"2019062610014234600_rky002-B13","doi-asserted-by":"crossref","first-page":"2437","DOI":"10.1002\/1529-0131(200011)43:11<2437::AID-ANR10>3.0.CO;2-U","article-title":"Severe organ involvement in systemic sclerosis with diffuse scleroderma","volume":"43","author":"Steen","year":"2000","journal-title":"Arthritis Rheum"},{"key":"2019062610014234600_rky002-B14","doi-asserted-by":"crossref","first-page":"2422","DOI":"10.1002\/art.22721","article-title":"Relationship between change in skin score and disease outcome in diffuse cutaneous systemic sclerosis","volume":"56","author":"Shand","year":"2007","journal-title":"Arthritis Rheumatol"},{"key":"2019062610014234600_rky002-B15","doi-asserted-by":"crossref","first-page":"104","DOI":"10.1136\/ard.2009.127621","article-title":"Skin thickness progression rate: a predictor of mortality and early internal organ involvement in diffuse scleroderma","volume":"70","author":"Domsic","year":"2011","journal-title":"Ann Rheum Dis"},{"key":"2019062610014234600_rky002-B16","doi-asserted-by":"crossref","first-page":"1989","DOI":"10.1056\/NEJMra0806188","article-title":"Scleroderma","volume":"360","author":"Gabrielli","year":"2009","journal-title":"N Eng J Med"},{"key":"2019062610014234600_rky002-B17","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1016\/j.rdc.2007.10.001","article-title":"Genetics and genomic studies in scleroderma (systemic sclerosis)","volume":"34","author":"Agarwal","year":"2008","journal-title":"Rheum Dis Clin N Am"},{"key":"2019062610014234600_rky002-B18","doi-asserted-by":"crossref","first-page":"e1002178","DOI":"10.1371\/journal.pgen.1002178","article-title":"Identification of novel genetic markers associated with clinical phenotypes of systemic sclerosis through a genome-wide association strategy","volume":"7","author":"Gorlova","year":"2011","journal-title":"PLoS Genet"},{"key":"2019062610014234600_rky002-B19","doi-asserted-by":"crossref","first-page":"983","DOI":"10.1136\/ard.54.12.983","article-title":"HLA class II genes associated with anticentromere antibody in Japanese patients with systemic sclerosis (scleroderma)","volume":"54","author":"Kuwana","year":"1995","journal-title":"Ann Rheum Dis"}],"container-title":["Rheumatology Advances in Practice"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/academic.oup.com\/rheumap\/article-pdf\/2\/1\/rky002\/28865967\/rky002.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,6,26]],"date-time":"2019-06-26T10:01:56Z","timestamp":1561543316000},"score":1,"resource":{"primary":{"URL":"https:\/\/academic.oup.com\/rheumap\/article\/doi\/10.1093\/rap\/rky002\/4924519"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,1,1]]},"references-count":19,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2018,3,7]]},"published-print":{"date-parts":[[2018,1,1]]}},"URL":"https:\/\/doi.org\/10.1093\/rap\/rky002","relation":{},"ISSN":["2514-1775"],"issn-type":[{"value":"2514-1775","type":"electronic"}],"subject":[],"published-other":{"date-parts":[[2018]]},"published":{"date-parts":[[2018,1,1]]},"article-number":"rky002"}}